HTA - 11/129/187
Human papillomavirus infection: a randomised controlled trial of Imiquimod versus Podophyllotoxin, in combination with quadrivalent human papillomavirus vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac Trial)
Project title: Human papillomavirus infection: a randomised controlled trial of Imiquimod versus Podophyllotoxin, in combination with quadrivalent human papillomavirus vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac Trial)
Chief investigator: Dr Richard Gilson
Contractor: University College London
Co-investigators: Dr Kate Soldan, Dr Lewis Haddow, Dr Mayura Nathan, Miss Michelle Tetlow, Professor Andrew Copas, Professor Caroline Dore, Professor Charles Lacey, Professor Mark Jit.
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research